Stay updated on M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the number of participants enrolled in the study testing the safety and effectiveness of M7824 in combination with gemcitabine for pancreatic cancer treatment.
    Difference
    0.1%
    Check dated 2024-06-06T14:34:09.000Z thumbnail image
  6. Check
    20 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying that researchers look for individuals who meet certain health conditions or treatment histories. The new criteria include the ability to understand and sign a consent document, being 18 years or older, and having specific health and treatment conditions.
    Difference
    41%
    Check dated 2024-05-22T21:21:51.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:35:22.000Z thumbnail image

Stay in the know with updates to M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial page.